Home › Funds › PUZO MICHAEL J › VRTX

PUZO MICHAEL J position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

PUZO MICHAEL J reported holding 15,386 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$8.0M, representing 2.17% of its reported portfolio and ranking #21 among its reported holdings. PUZO MICHAEL J has disclosed VRTX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)15.39K sh
Reported value held$8.04M
Portfolio Weight2.17%
First reportedQ4 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How PUZO MICHAEL J's VRTX position evolved

PUZO MICHAEL J first disclosed a stake in VRTX in Q4 2023 at 850 shares (US$346K). The position peaked in Q3 2026 at 15,386 shares, worth US$8.0M. Across 12 filings, PUZO MICHAEL J increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 15,386 shares valued at US$8.0M — a reduction of -521 shares quarter over quarter.. Notable position changes include a 443% increase in Q1 2024 (shares rose 12% over the following quarter), a 107% increase in Q2 2024 (shares were roughly flat over the following quarter), a 28% increase in Q3 2024 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 850 $345.86K New
Q1 2024 4.61K $1.93M Add
Q2 2024 9.57K $4.48M Add
Q3 2024 12.24K $5.69M Add
Q4 2024 14.11K $5.68M Add
Q1 2025 15.29K $7.41M Add
Q2 2025 15.34K $6.83M Hold
Q3 2025 15.50K $6.07M Add
Q4 2025 15.37K $6.97M Reduce
Q1 2026 15.41K $6.88M Hold
Q2 2026 15.91K $7.90M Add
Q3 2026 15.39K $8.04M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has PUZO MICHAEL J held VRTX?

PUZO MICHAEL J has disclosed VRTX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is PUZO MICHAEL J's current position in VRTX?

As of Q3 2026, PUZO MICHAEL J holds 15.39K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $8.04M, representing 2.17% of its reported portfolio and ranking #21.

Has PUZO MICHAEL J been buying or selling VRTX?

In the latest 13F filing (Q3 2026), PUZO MICHAEL J reduced its position in VRTX. The position peaked in Q3 2026 at 15.39K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.